Bottom line
XPAY vs IVV: the short answer
XPAY (Roundhill S&P 500 Target 20 Managed Distribution ETF) and IVV (iShares Core S&P 500 ETF) are both etfs.
But IVV is far broader, holding 507 positions to 15 for XPAY, so beyond the top names it adds exposure XPAY doesn't have.
IVV is cheaper at 0.03% vs 0.49% — a difference of $46 a year per $10,000 invested.
Over one year, IVV returned +17.8% vs +16.7% for XPAY.
Updated Nov 19, 2026
XPAY vs IVV side by side
| XPAY | IVV | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Roundhill | iShares |
| Category | S&P 500 Index | S&P 500 Index |
| Expense ratio | 0.49% | 0.03% |
| Annual cost per $10k | $49 | $3 |
| 10-yr cost on $10k (prospectus) | $616 | $39 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +16.7% | +17.8% |
| 5-yr return (annualized) | — | +14.4% |
| 10-yr return (annualized) | — | +14.8% |
| Best quarter | +10.8% | +20.5% |
| Worst quarter | −4.8% | −19.6% |
| Net assets (fund) | $155.4M | $701.4B |
| Number of holdings | 15 | 507 |
| Portfolio turnover | 1% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | XPAY | IVV | Difference |
|---|---|---|---|
| 2025 | +16.7% | +17.8% | −1.1% |
Source: Fund prospectus bar charts
Holdings overlap
XPAY and IVV share none of their top holdings.
XPAY top 10
- N/a — 15.46%
- N/a — 12.95%
- N/a — 12.92%
- N/a — 11.33%
- N/a — 7.82%
- N/a — 7.19%
- N/a — 6.19%
- First American Government Obli — 4.86%
- N/a — 4.76%
- N/a — 4.32%
IVV top 10
- NVIDIA Corp. — 7.97%
- Microsoft Corp. — 6.74%
- Apple, Inc. — 6.61%
- Amazon.com, Inc. — 3.73%
- Meta Platforms, Inc. — 2.79%
- Broadcom, Inc. — 2.72%
- Alphabet, Inc. — 2.47%
- Tesla, Inc. — 2.18%
- Alphabet, Inc. — 1.99%
- Berkshire Hathaway, Inc. — 1.61%
FAQ
What is the difference between XPAY and IVV?
Which is cheaper, XPAY or IVV?
Should I own both XPAY and IVV?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.